만성 가려움증 치료제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 연간 평균 성장률(CAGR) 7.3%로 성장할 전망이며, 144억 9,000만 달러로 성장이 예측됩니다. 예측 기간 동안의 성장은 인지도 상승, 아토피 피부염 유병률 증가, 맞춤형 의료에 대한 관심 증가, 피부과 질환 이환율 상승, 환자 인구 증가와 같은 요인에 기인할 것으로 전망됩니다. 이 기간 주요 동향으로는 혁신적 의약품 도입, 신규 생물제제 및 표적요법 개발, 기술 발전, 첨단 약물 전달 시스템 통합, 제약기업 및 연구기관의 제휴, 원격 의료를 포함한 디지털 헬스 기술 도입 등을 들 수 있습니다.
아토피 피부염의 유병률 상승이 만성 가려움증 치료제 시장의 성장을 견인할 것으로 예측됩니다. 아토피피부염(AD)은 발적, 가려움, 건조, 염증 등의 증상을 특징으로 하는 만성 염증성 피부질환입니다. 아토피 피부염은 알레르기, 천식, 꽃가루 알레르기 등의 가족력이 있는 사람에게 자주 발병합니다. 아토피 피부염의 유병률 증가는 유전적 소인, 환경의 변화, 생활습관, 위생가설, 알레르겐 노출의 증가, 피부 마이크로바이옴의 불균형 등의 요인에 기인할 것으로 전망됩니다. 만성 가려움증 치료제는 근본적인 염증 경로를 표적으로 하여 피부 자극을 줄이고 환자의 쾌적성을 높임으로써 아토피 피부염에 동반된 지속적인 가려움증을 완화하는데 도움을 줍니다. 예를 들어 2022년 국제습진협의회가 발표한 아토피 피부염 환자 수는 전 세계적으로 약 2억 2,300만 명이었고, 그 중 1-4세 소아는 4,300만 명이었습니다. 그 결과 아토피 피부염의 유병률 증가가 만성 가려움증 치료제 시장의 확대를 견인하고 있습니다.
만성 가려움증 치료제 시장의 주요 기업은 치료 효과를 향상시키고 환자를 신속하게 구제하기 위해 정맥 주사 요법 등의 혁신적인 치료법의 개발에 주력하고 있습니다. 정맥 주사는 항히스타민제나 부신피질 스테로이드제 등의 약제를 혈류에 직접 보내 가려움증 및 염증을 신속하게 완화합니다. 예를 들면, 미국을 거점으로 하는 Cara Therapeutics Inc.는, 2023년 9월, 파트너 기업인 마루이시 제약 주식회사가, 일본에서 항히스타민약이나 코르티코스테로이드약의 제조 판매 승인을 취득했다고 발표했습니다. 하지만, 일본의 후생 노동성으로부터 코르스바 정주 주사기의 승인을 취득했다고 발표했습니다. 혈액투석 환자의 가려움증을 대상으로 한 이 치료는 제3상 임상시험에서 위약과 비교하여 가려움 점수의 유의한 개선을 보였으며, 환자로부터의 인용성도 양호했습니다. 이 승인에 의해, 마루이시 제약과의 라이센스 계약에 근거해, 카라 세라퓨틱스사에 150만 달러의 마일스톤이 지불되게 됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 만성 가려움증 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 만성 가려움증 치료제 시장 : 성장률 분석
- 세계의 만성 가려움증 치료제 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 만성 가려움증 치료제 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 만성 가려움증 치료제 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 만성 가려움증 치료제 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 코르티코스테로이드
- 항히스타민제
- 국소 마취제
- 역자극제
- 면역억제제
- 칼시뉴린 억제제
- 기타 제품 유형
- 세계의 만성 가려움증 치료제 시장 : 질환 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 아토피 피부염
- 알레르기성 접촉 피부염
- 두드러기
- 기타 질병의 유형
- 세계의 만성 가려움증 치료제 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 약국 및 소매 약국
- 온라인 제공업체
- 세계의 만성 가려움증 치료제 시장 : 코르티코스테로이드 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 코르티코스테로이드
- 경구 코르티코스테로이드
- 주사용 코르티코스테로이드
- 세계의 만성 가려움증 치료제 시장 : 항히스타민제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 제1세대 항히스타민제
- 제2세대 항히스타민제
- 세계의 만성 가려움증 치료제 시장 : 국소 마취제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 국소 마취제
- 주사용 국소 마취제
- 세계의 만성 가려움증 치료제 시장 : 항자극제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 멘톨 기반의 항자극제
- 장뇌 기반의 항자극제
- 세계의 만성 가려움증 치료제 시장 : 면역억제제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 전신 면역억제제
- 국소 면역억제제
- 세계의 만성 가려움증 치료제 시장 : 칼시뉴린 억제제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 타크로리무스 기반 치료
- 피메클로리무스 기반 치료
- 세계의 만성 가려움증 치료제 시장 : 기타 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 생물학적 요법
- 새로운 치료법의 출현
제7장 지역별 및 국가별 분석
- 세계의 만성 가려움증 치료제 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 만성 가려움증 치료제 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 만성 가려움증 치료제 시장 : 경쟁 구도
- 만성 가려움증 치료제 시장 : 기업 프로파일
- Pfizer Incorporated 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Sanofi SA 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis Aktiengesellschaft 개요, 제품 및 서비스, 전략 및 재무 분석
- GlaxoSmithKline plc 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Toray Industries Inc.
- CSL Behring LLC
- Regeneron Pharmaceuticals Inc.
- Astellas Pharma Inc.
- Ipsen SA
- Incyte Corporation
- Cipla Limited
- H. Lundbeck A/S
- Sumitomo Pharma Co. Ltd.
- Mallinckrodt Pharmaceuticals plc
- Kissei Pharmaceutical Co. Ltd.
- Asana BioSciences LLC
- Vanda Pharmaceuticals Inc.
- Dermavant Sciences Inc.
- Galderma Laboratories LP
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 만성 가려움증 치료제 시장(2029년) : 새로운 기회를 제공하는 국가
- 만성 가려움증 치료제 시장(2029년) : 새로운 기회를 제공하는 부문
- 만성 가려움증 치료제 시장(2029년) : 성장 전략
제36장 부록
AJY
Chronic pruritus therapy refers to treatments designed to manage or relieve persistent itching (pruritus) that lasts for six weeks or more. Managing chronic pruritus involves a combination of therapies tailored to the underlying cause, with treatment adjustments based on the patient's response.
The main product types for chronic pruritus therapeutics include corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressants, calcineurin inhibitors, and other treatments. Corticosteroids are medications that reduce inflammation and itching by suppressing the immune system's response, making them effective for treating chronic pruritus and inflammatory skin conditions. These products are used for various conditions, including atopic dermatitis, allergic contact dermatitis, urticaria, and others. They are distributed through multiple channels, such as hospital pharmacies, drug stores, retail pharmacies, and online providers.
The chronic pruritus therapeutics market research report is one of a series of new reports from The Business Research Company that provides chronic pruritus therapeutics market statistics, including the chronic pruritus therapeutics industry global market size, regional shares, competitors with the chronic pruritus therapeutics market share, detailed chronic pruritus therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic pruritus therapeutics industry. This chronic pruritus therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The chronic pruritus therapeutics market size has grown strongly in recent years. It will grow from $10.17 billion in 2024 to $10.94 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to factors such as the rising prevalence of chronic pruritus, increasing demand for effective treatments, growing regulatory approvals, a rise in product approvals, and an increase in mergers, collaborations, and acquisitions among industry participants.
The chronic pruritus therapeutics market size is expected to see strong growth in the next few years. It will grow to $14.49 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be attributed to factors such as rising awareness, the increasing prevalence of atopic dermatitis, a growing focus on personalized medicine, the rising incidence of dermatological conditions, and a growing patient population. Key trends during this period include the introduction of innovative medicines, the development of novel biologics and targeted therapies, technological advancements, the integration of advanced drug delivery systems, collaborations between pharmaceutical companies and research institutions, and the adoption of digital health technologies, including telemedicine.
The rising prevalence of atopic dermatitis is expected to drive the growth of the chronic pruritus therapeutics market. Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by symptoms such as redness, itching, dryness, and irritation. It commonly affects individuals with a family history of allergies, asthma, or hay fever. The increasing prevalence of atopic dermatitis can be attributed to factors such as genetic predisposition, environmental changes, lifestyle habits, the hygiene hypothesis, increased allergen exposure, and imbalances in the skin microbiome. Chronic pruritus therapeutics help alleviate the persistent itching associated with atopic dermatitis by targeting the underlying inflammatory pathways, reducing skin irritation, and enhancing patient comfort. For example, in 2022, the International Eczema Council reported that approximately 223 million people worldwide were living with atopic dermatitis, including 43 million children aged 1-4, emphasizing the condition's high prevalence in early childhood. As a result, the growing prevalence of atopic dermatitis is driving the expansion of the chronic pruritus therapeutics market.
Key companies in the chronic pruritus therapeutics market are focusing on developing innovative treatments, such as intravenous (IV) injection therapies, to improve treatment efficacy and provide quicker relief for patients. IV injections deliver medications such as antihistamines or corticosteroids directly into the bloodstream, offering fast relief from itching and inflammation. For example, in September 2023, Cara Therapeutics Inc., a U.S.-based company, announced that its partner company Maruishi Pharmaceutical Co. Ltd. received approval from Japan's Ministry of Health, Labour and Welfare for the Korsuva IV injection syringe. This treatment, aimed at pruritus in hemodialysis patients, showed significant improvements in itching scores compared to a placebo in Phase 3 clinical trials and was well-tolerated by patients. The approval also triggered a $1.5 million milestone payment to Cara Therapeutics under the terms of their licensing agreement with Maruishi.
In May 2024, Incyte Corporation, a U.S.-based biopharmaceutical company, acquired Escient Pharmaceuticals for $750 million. This acquisition aims to strengthen Incyte's Inflammation and Autoimmunity (IAI) pipeline by integrating innovative therapies targeting severe inflammatory diseases. Escient Pharmaceuticals is a U.S.-based biotechnology company specializing in therapeutics for uremic pruritus.
Major players in the chronic pruritus therapeutics market are Pfizer Incorporated, AbbVie Inc., Sanofi S.A., Novartis Aktiengesellschaft, GlaxoSmithKline plc, Toray Industries Inc., CSL Behring LLC, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Ipsen S.A., Incyte Corporation, Cipla Limited, H. Lundbeck A/S, Sumitomo Pharma Co. Ltd., Mallinckrodt Pharmaceuticals plc, Kissei Pharmaceutical Co. Ltd., Asana BioSciences LLC, Vanda Pharmaceuticals Inc., Dermavant Sciences Inc., Galderma Laboratories L.P., Cara Therapeutics Inc., Avior Bio Inc., Trevi Therapeutics Inc.
North America was the largest region in the chronic pruritus therapeutics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic pruritus therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the chronic pruritus therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chronic pruritus therapeutics market consists of sales of capsaicin creams, jak inhibitors, systemic therapies, phototherapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chronic Pruritus Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on chronic pruritus therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for chronic pruritus therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic pruritus therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Corticosteroid; Antihistamine; Local Anesthetic; Counterirritant; Immunosuppressant; Calcineurin Inhibitors; Other Product Types
- 2) By Disease Type: Atopic Dermatitis; Allergic Contact Dermatitis; Urticaria; Other Disease Types
- 3) By Distribution Channel: Hospital Pharmacies; Drug stores And Retail Pharmacies; Online Providers
- Subsegments:
- 1) By Corticosteroid: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids
- 2) By Antihistamine: First-Generation Antihistamines; Second-Generation Antihistamines
- 3) By Local Anesthetic: Topical Local Anesthetics; Injectable Local Anesthetics
- 4) By Counterirritant: Menthol-Based Counterirritants; Camphor-Based Counterirritants
- 5) By Immunosuppressant: Systemic Immunosuppressants; Topical Immunosuppressants
- 6) By Calcineurin Inhibitors: Tacrolimus-Based Therapy; Pimecrolimus-Based Therapy
- 7) By Other Product Types: Biologic Therapies; Emerging Novel Therapies
- Companies Mentioned: Pfizer Incorporated; AbbVie Inc.; Sanofi S.A.; Novartis Aktiengesellschaft; GlaxoSmithKline plc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Chronic Pruritus Therapeutics Market Characteristics
3. Chronic Pruritus Therapeutics Market Trends And Strategies
4. Chronic Pruritus Therapeutics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Chronic Pruritus Therapeutics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Chronic Pruritus Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Chronic Pruritus Therapeutics Market Growth Rate Analysis
- 5.4. Global Chronic Pruritus Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Chronic Pruritus Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Chronic Pruritus Therapeutics Total Addressable Market (TAM)
6. Chronic Pruritus Therapeutics Market Segmentation
- 6.1. Global Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Corticosteroid
- Antihistamine
- Local Anesthetic
- Counterirritant
- Immunosuppressant
- Calcineurin Inhibitors
- Other Product Types
- 6.2. Global Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Atopic Dermatitis
- Allergic Contact Dermatitis
- Urticaria
- Other Disease Types
- 6.3. Global Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Drug stores And Retail Pharmacies
- Online Providers
- 6.4. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Corticosteroids
- Oral Corticosteroids
- Injectable Corticosteroids
- 6.5. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Antihistamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- First-Generation Antihistamines
- Second-Generation Antihistamines
- 6.6. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Local Anesthetic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Local Anesthetics
- Injectable Local Anesthetics
- 6.7. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Counterirritant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Menthol-Based Counterirritants
- Camphor-Based Counterirritants
- 6.8. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Immunosuppressant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Systemic Immunosuppressants
- Topical Immunosuppressants
- 6.9. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tacrolimus-Based Therapy
- Pimecrolimus-Based Therapy
- 6.10. Global Chronic Pruritus Therapeutics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biologic Therapies
- Emerging Novel Therapies
7. Chronic Pruritus Therapeutics Market Regional And Country Analysis
- 7.1. Global Chronic Pruritus Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Chronic Pruritus Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Chronic Pruritus Therapeutics Market
- 8.1. Asia-Pacific Chronic Pruritus Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Chronic Pruritus Therapeutics Market
- 9.1. China Chronic Pruritus Therapeutics Market Overview
- 9.2. China Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Chronic Pruritus Therapeutics Market
- 10.1. India Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Chronic Pruritus Therapeutics Market
- 11.1. Japan Chronic Pruritus Therapeutics Market Overview
- 11.2. Japan Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Chronic Pruritus Therapeutics Market
- 12.1. Australia Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Chronic Pruritus Therapeutics Market
- 13.1. Indonesia Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Chronic Pruritus Therapeutics Market
- 14.1. South Korea Chronic Pruritus Therapeutics Market Overview
- 14.2. South Korea Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Chronic Pruritus Therapeutics Market
- 15.1. Western Europe Chronic Pruritus Therapeutics Market Overview
- 15.2. Western Europe Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Chronic Pruritus Therapeutics Market
- 16.1. UK Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Chronic Pruritus Therapeutics Market
- 17.1. Germany Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Chronic Pruritus Therapeutics Market
- 18.1. France Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Chronic Pruritus Therapeutics Market
- 19.1. Italy Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Chronic Pruritus Therapeutics Market
- 20.1. Spain Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Chronic Pruritus Therapeutics Market
- 21.1. Eastern Europe Chronic Pruritus Therapeutics Market Overview
- 21.2. Eastern Europe Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Chronic Pruritus Therapeutics Market
- 22.1. Russia Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Chronic Pruritus Therapeutics Market
- 23.1. North America Chronic Pruritus Therapeutics Market Overview
- 23.2. North America Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Chronic Pruritus Therapeutics Market
- 24.1. USA Chronic Pruritus Therapeutics Market Overview
- 24.2. USA Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Chronic Pruritus Therapeutics Market
- 25.1. Canada Chronic Pruritus Therapeutics Market Overview
- 25.2. Canada Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Chronic Pruritus Therapeutics Market
- 26.1. South America Chronic Pruritus Therapeutics Market Overview
- 26.2. South America Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Chronic Pruritus Therapeutics Market
- 27.1. Brazil Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Chronic Pruritus Therapeutics Market
- 28.1. Middle East Chronic Pruritus Therapeutics Market Overview
- 28.2. Middle East Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Chronic Pruritus Therapeutics Market
- 29.1. Africa Chronic Pruritus Therapeutics Market Overview
- 29.2. Africa Chronic Pruritus Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Chronic Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Chronic Pruritus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Chronic Pruritus Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. Chronic Pruritus Therapeutics Market Competitive Landscape
- 30.2. Chronic Pruritus Therapeutics Market Company Profiles
- 30.2.1. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
31. Chronic Pruritus Therapeutics Market Other Major And Innovative Companies
- 31.1. Toray Industries Inc.
- 31.2. CSL Behring LLC
- 31.3. Regeneron Pharmaceuticals Inc.
- 31.4. Astellas Pharma Inc.
- 31.5. Ipsen S.A.
- 31.6. Incyte Corporation
- 31.7. Cipla Limited
- 31.8. H. Lundbeck A/S
- 31.9. Sumitomo Pharma Co. Ltd.
- 31.10. Mallinckrodt Pharmaceuticals plc
- 31.11. Kissei Pharmaceutical Co. Ltd.
- 31.12. Asana BioSciences LLC
- 31.13. Vanda Pharmaceuticals Inc.
- 31.14. Dermavant Sciences Inc.
- 31.15. Galderma Laboratories L.P.
32. Global Chronic Pruritus Therapeutics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Chronic Pruritus Therapeutics Market
34. Recent Developments In The Chronic Pruritus Therapeutics Market
35. Chronic Pruritus Therapeutics Market High Potential Countries, Segments and Strategies
- 35.1 Chronic Pruritus Therapeutics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Chronic Pruritus Therapeutics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Chronic Pruritus Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
